Enzyme I of the phosphotransferase system: induced-fit protonation of the reaction transition state by Cys-502

Autor: Bernhard Erni, Luis F. García-Alles, Ignacio Alfonso
Přispěvatelé: Universidad de Oviedo, Universidad de Oviedo [Oviedo]
Rok vydání: 2003
Předmět:
[SDV.BIO]Life Sciences [q-bio]/Biotechnology
Protein Conformation
Biochemistry
Phosphoenolpyruvate
chemistry.chemical_compound
MESH: Protein Conformation
MESH: Structure-Activity Relationship
Enzyme Inhibitors
0303 health sciences
Oxalates
MESH: Kinetics
Chemistry
030302 biochemistry & molecular biology
PEP group translocation
MESH: Oxalates
MESH: Enzyme Inhibitors
MESH: Phosphoenolpyruvate
cardiovascular system
Protons
Phosphoenolpyruvate carboxykinase
Dimerization
Steric effects
MESH: Mutation
Stereochemistry
education
Substituent
Protonation
MESH: Phosphoenolpyruvate Sugar Phosphotransferase System
Oxalate
Catalysis
03 medical and health sciences
Structure-Activity Relationship
Isomerism
MESH: Isomerism
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Cysteine
Binding site
Phosphoenolpyruvate Sugar Phosphotransferase System
030304 developmental biology
Binding Sites
MESH: Phosphotransferases (Nitrogenous Group Acceptor)
Phosphotransferases (Nitrogenous Group Acceptor)
Substrate (chemistry)
MESH: Cysteine
MESH: Catalysis
Kinetics
MESH: Binding Sites
MESH: Dimerization
Mutation
MESH: Protons
Zdroj: Biochemistry
Biochemistry, American Chemical Society, 2003, 42 (16), pp.4744-4750. ⟨10.1021/bi034007f⟩
ISSN: 0006-2960
1520-4995
Popis: International audience; Enzyme I (EI), the first component of the phosphoenolpyruvate (PEP):sugar phosphotransferase system (PTS), consists of an N-terminal domain with the phosphorylation site (His-189) and a C-terminal domain with the PEP binding site. Here we use C3-substituted PEP analogues as substrates and inhibitors and the EI(C502A) mutant to characterize structure-activity relationships of the PEP binding site. EI(C502A) is 10 000 times less active than wild-type EI [EI(wt)] with PEP as the substrate, whereas the two forms are equally active with ZClPEP. Cys-502 acts as an acid-base catalyst which stereospecifically protonates the pyruvoyl enolate at C3. The electron-withdrawing chlorine of ZClPEP can compensate for the lack of Cys-502, and in this case, the released 3-Cl-enolate is protonated nonstereospecifically. Several PEP analogues were assayed as inhibitors and as substrates. The respective K(I)/K(m) ratios vary between 3 and 40 for EI(wt), but they are constant and around unity for EI(C502A). EI(wt) with PEP as the substrate is inhibited by oxalate, whereas EI(C502A) with ZClPEP is not. The different behavior of EI(wt) and EI(C502A) toward the PEP analogues and oxalate suggests that the PEP binding site of EI(wt) exists in a "closed" and an "open" form. The open to closed transition is triggered by the interaction of the substrate with Cys-502. The closed conformation is sterically disfavored by C3-modified substrate analogues such as ZClPEP and ZMePEP. If site closure does not occur as with EI(C502A) and bulky substrates, the transition state is stabilized by electron dispersion to the electron-withdrawing substituent at C3.
Databáze: OpenAIRE